Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Receives Average Recommendation of “Buy” from Brokerages
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) has earned an average recommendation of “Buy” from the nine analysts that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The […]
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) has earned an average recommendation of “Buy” from the nine analysts that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The […]
